Tubutecan antibody drug conjugate (Bristol Myers Squibb)

N/A

Report date: 2025/06/17 14:18:12

Base Information

Drug NameTubutecan antibody drug conjugate (Bristol Myers Squibb)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payload

Mechanisms of ActionDNA topoisomerase I inhibitors

TargetsDNA topoisomerase I

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesTubulis GmbH

China Registration ClassN/A

Develop Information

Active CompaniesTubulis GmbH

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A